Search Patents
  • Patent number: 7807429
    Abstract: The present invention relates to an isolated nucleic acid and polypeptide sequence that encodes for a luciferase of Luciola italica, as well as mutants thereof. The luciferase proteins of the present invention have been found to have extended bioluminescence emission that is red- or blue-shifted, and are useful as a bioluminescent marker or as an additive to selected materials.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: October 5, 2010
    Assignee: Connecticut College
    Inventors: Bruce R. Branchini, Tara L. Southworth, Jennifer P. DeAngelis, Aldo Roda, Elisa Michelini
  • Publication number: 20110171669
    Abstract: The present invention relates to an isolated nucleic acid and polypeptide sequence that encodes for a luciferase of Luciola italica, as well as mutants thereof. The luciferase proteins of the present invention have been found to have extended bioluminescence emission that is red- or blue-shifted, and are useful as a bioluminescent marker or as an additive to selected materials.
    Type: Application
    Filed: October 1, 2010
    Publication date: July 14, 2011
    Inventors: Bruce R. Branchini, Tara L. Southworth, Jennifer P. DeAngelis, Aldo Roda, Elisa Michelini
  • Patent number: 6962986
    Abstract: Isolated nucleic acid molecules which code for luciferases able to produce the green bioluminescence of Phrixotrhix vivianii and red bioluminescence of Phrixothrix hirtus are described. The nucleic acid molecules and the luciferases encoded thereby can be used in applications such as diagnostic methods and molecular biology tools.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: November 8, 2005
    Assignee: Toyo Boseki Kabushiki Kaisha
    Inventors: Vadim R. Viviani, Yoshihiro Ohmiya
  • Patent number: 7276363
    Abstract: Isolated nucleic acid molecules which code for luciferases able to produce the green bioluminescence of Phrixotrhix vivianii and red bioluminescence of Phrixothrix hirtus are described. The nucleic acid molecules and the luciferases encoded thereby can be used in applications such as diagnostic methods and molecular biology tools.
    Type: Grant
    Filed: September 14, 2004
    Date of Patent: October 2, 2007
    Assignee: Toyo Boseki Kabushiki Kaisha
    Inventors: Vadim R. Viviani, Yoshihiro Ohmiya
  • Patent number: 8642272
    Abstract: The present invention relates to an isolated nucleic acid and polypeptide sequence that encodes for a luciferase of Luciola italica, as well as mutants thereof. The luciferase proteins of the present invention have been found to have extended bioluminescence emission that is red- or blue-shifted, and are useful as a bioluminescent marker or as an additive to selected materials.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: February 4, 2014
    Assignee: Connecticut College
    Inventors: Bruce R. Branchini, Tara L. Southworth, Jennifer P. DeAngelis, Aldo Roda, Elisa Michelini
  • Publication number: 20080299592
    Abstract: The compositions described herein shift the light output of luciferases to the near-IR by resonance energy transfer to a targetable near-IR fluorophore.
    Type: Application
    Filed: February 29, 2008
    Publication date: December 4, 2008
    Inventor: Stephen C. Miller
  • Patent number: 8183036
    Abstract: A modified beetle luciferase protein which is an environmentally sensitive reporter protein is provided.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: May 22, 2012
    Assignee: Promega Corporation
    Inventors: Frank Fan, Martin Ken Lewis, John W. Shultz, Keith V. Wood, Braeden Butler
  • Publication number: 20100184185
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 22, 2007
    Publication date: July 22, 2010
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20100105090
    Abstract: The invention relates to the nucleotide and amino acid sequences and to the activity and use of the secreted MLuc7 luciferase.
    Type: Application
    Filed: January 26, 2008
    Publication date: April 29, 2010
    Applicant: BAYER HEALTHCARE AG
    Inventors: Stefan Golz, Eugene Vysotski, Svetlana Markova, Anna Tumenceva
  • Publication number: 20100035287
    Abstract: The present invention relates generally to methods to monitor the transport of proteins through the secretory pathway, and methods to monitor ER stress. In particular, the present invention relates to methods to monitor, in real-time, the processing of protein through the secretory pathway, which can be monitored both at a subcellular level by florescence visualization and quantitatively by detecting the secreted luciferase reporter protein. The present invention also relates to methods to assess biological processes in cells, in particular the secretory pathway and ER stress, as well as methods to identify agents which augment or inhibit the secretory pathway and/or ER stress. The present invention also relates to compositions and nucleic constructs encoding a secreted luciferase-fluorescent protein conjugate for methods to monitor protein trafficking in the cell by simultaneous detection of fluorescence and luciferase secretion.
    Type: Application
    Filed: October 12, 2007
    Publication date: February 11, 2010
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Bakhos A. Tannous, Xandra Breakefield, Jeffrey W. Hewett
  • Publication number: 20140201855
    Abstract: Described are mutant luciferases, nucleic acids that encode them, cells and animals expressing them, methods of use thereof, and kits.
    Type: Application
    Filed: February 9, 2012
    Publication date: July 17, 2014
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Stephen C. Miller, David Mofford, Katryn Harwood
  • Publication number: 20040219527
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 1, 2003
    Publication date: November 4, 2004
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Patent number: 8378086
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: February 19, 2013
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu
  • Publication number: 20140227759
    Abstract: An isolated polynucleotide encoding a modified luciferase polypeptide and substrates. The OgLuc variant polypeptide has at least 60% amino acid sequence identity to SEQ ID NO: 1 and at least one amino acid substitution at a position corresponding to an amino acid in SEQ ID NO: 1. The OgLuc variant polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the corresponding polypeptide of the wild-type Oplophorus luciferase.
    Type: Application
    Filed: January 21, 2014
    Publication date: August 14, 2014
    Applicant: PROMEGA CORPORATION
    Inventors: Brock Binkowski, Lance P. Encell, Mary Hall, Matthew B. Robers, Michael R. Slater, Keith V. Wood, Monika G. Wood
  • Publication number: 20090136998
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Application
    Filed: September 6, 2006
    Publication date: May 28, 2009
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu
  • Publication number: 20130115641
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: July 18, 2012
    Publication date: May 9, 2013
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Stefan GOLZ, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Patent number: 8669103
    Abstract: An isolated polynucleotide encoding a modified luciferase polypeptide and substrates. The OgLuc variant polypeptide has at least 60% amino acid sequence identity to SEQ ID NO: 1 and at least one amino acid substitution at a position corresponding to an amino acid in SEQ ID NO: 1. The OgLuc variant polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the corresponding polypeptide of the wild-type Oplophorus luciferase.
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: March 11, 2014
    Assignee: Promega Corporation
    Inventors: Brock Binkowski, Lance P. Encell, Mary Hall, Matthew B. Robers, Michael R. Slater, Keith V. Wood, Monika G. Wood
  • Patent number: 7939649
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: May 10, 2011
    Assignees: Stanford University, Regents of University of California
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu
  • Publication number: 20140223590
    Abstract: An isolated polynucleotide encoding a modified luciferase polypeptide and substrates. The OgLuc variant polypeptide has at least 60% amino acid sequence identity to SEQ ID NO: 1 and at least one amino acid substitution at a position corresponding to an amino acid in SEQ ID NO: 1. The OgLuc variant polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the corresponding polypeptide of the wild-type Oplophorus luciferase.
    Type: Application
    Filed: January 21, 2014
    Publication date: August 7, 2014
    Applicant: Promego Corporation
    Inventors: Brock Binkowski, Lance P. Encell, Mary Hall, Matthew B. Robers, Michael R. Slater, Keith V. Wood, Monika G. Wood
  • Publication number: 20110229955
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Application
    Filed: March 24, 2011
    Publication date: September 22, 2011
    Applicants: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu